Tyrolean Cancer Research Institute
Impact in
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 164
- Cancer Cells and Metastasis 35
- Cancer-related Molecular Pathways 22
- Hematology 59
- Chronic Myeloid Leukemia Treatments 24
- Top scholars
- Reinhard KoflerMichael J. AusserlechnerDominik Georg Friedrich WolfPetra ObexerPidder Jansen‐DürrWilli OberaignerGuenther A. GastlWerner Zwerschke
- Journals
- Oncotarget (12 papers)International Journal of Cancer (11 papers)PLoS ONE (10 papers)Oncogene (10 papers)Blood (10 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Tyrolean Cancer Research Institute
502 papers receiving 18.9k citations
Peers
Comparison fields: 5 of 190
- Oncology 5.6k
- Cancer Research 3.1k
- Immunology 3.8k
- Biological Psychiatry 431
- Hematology 1.5k
Countries citing scholars working at Tyrolean Cancer Research Institute
This map shows the geographic impact of research produced by authors working at Tyrolean Cancer Research Institute. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Tyrolean Cancer Research Institute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyrolean Cancer Research Institute more than expected).
Fields of papers published by authors at Tyrolean Cancer Research Institute
This network shows the impact of papers affiliated with Tyrolean Cancer Research Institute at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Tyrolean Cancer Research Institute at the time of their publication.
About Tyrolean Cancer Research Institute
In recent decades, authors affiliated with Tyrolean Cancer Research Institute have published 560 papers, which have received a total of 22.4k indexed citations . Scholars at this organization have produced 164 papers in Oncology, 59 papers in Hematology, 67 papers in Cancer Research, 89 papers in Immunology and 40 papers in Genetics on the topics of Immune Cell Function and Interaction (37 papers), Cancer Cells and Metastasis (35 papers), Cell death mechanisms and regulation (35 papers), Immunotherapy and Immune Responses (34 papers), Chronic Lymphocytic Leukemia Research (25 papers), Chronic Myeloid Leukemia Treatments (24 papers), Cancer-related Molecular Pathways (22 papers) and Cancer, Hypoxia, and Metabolism (21 papers). Their work is cited by papers focused on Oncology (5.6k citations), Cancer Research (3.1k citations), Immunology (3.8k citations), Biological Psychiatry (431 citations) and Hematology (1.5k citations). Authors at Tyrolean Cancer Research Institute collaborate with scholars in Austria, Germany and United States and have published in prestigious journals including Oncotarget, International Journal of Cancer, PLoS ONE, Oncogene and Blood. Some of Tyrolean Cancer Research Institute's most productive authors include Reinhard Kofler, Michael J. Ausserlechner, Dominik Georg Friedrich Wolf, Petra Obexer, Pidder Jansen‐Dürr, Willi Oberaigner, Guenther A. Gastl, Werner Zwerschke, Gilbert Spizzo and Richard Greil.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.